One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 350,000 shares of Pfizer Inc. (NYSE: PFE | PFE Price Prediction) on Friday, as the price of this fund was up over 2% in the day’s session. It is also up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 351,289 shares of Pfizer. At Friday’s closing price, this would have valued this purchase at roughly $16.4 million. This is only a small fraction of the total holdings. The fund is up 42% over the past 52 weeks.
Check out all the ARK Invest buys for Friday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | JD | JD.COM | 38,130 |
| ARKF | PDD | PINDUODUO | 62,767 |
| ARKF | TDOC | TELADOC HEALTH | 4,793 |
| ARKG | PFE | PFIZER | 351,289 |
| ARKG | QSI | QUANTUM-SI | 1,818 |
| ARKG | FATE | FATE THERAPEUTICS | 57,841 |
| ARKG | DYNS | DYNAMICS SPECIAL PURPOSE | 49,500 |
| ARKG | RPTX | REPARE THERAPEUTICS | 7,501 |
| ARKG | ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,000 |
| ARKG | PSNL | PERSONALIS | 5,444 |
| ARKK | SGFY | SIGNIFY HEALTH | 190,400 |
| ARKK | FATE | FATE THERAPEUTICS | 114,617 |
| ARKQ | ACIC | ATLAS CREST INVESTMENT | 190,900 |
| ARKQ | KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS | 59,400 |
| ARKQ | KMTUY | KOMATSU | 17,000 |
| ARKW | GENI | GENIUS SPORTS | 69,647 |
| ARKX | PRNT | 3D PRINTING ETF | 11,293 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=943368][wallst_email_signup]